Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Camel Insulin ELISA Kit (AC3852)
Cat.#: ASET-2441
Specifications
Description Camel Insulin ELISA Kit allows for the in vitro quantitative determination of camel Insulin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Camel Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1840 Human Neurexin 1 ELISA Kit (AC3251) Quantitative inquiry ASET-2130 Rat Adenosine Receptor A2a ELISA Kit (AC3541) Quantitative inquiry ASET-1293 Rat Prokineticin Receptor 1 ELISA Kit (AC2704) Quantitative inquiry ASET-2203 Human Dopamine D2 Receptor ELISA Kit (AC3614) Quantitative inquiry ASET-1194 Human VAMP2 ELISA Kit (AC2605) Quantitative inquiry ASET-2468 Mouse SIRP alpha ELISA Kit (AC3879) Quantitative inquiry ASET-1621 Mouse PPAR gamma ELISA Kit (AC3032) Quantitative inquiry ASET-1124 Human SOX3 ELISA Kit (AC2535) Quantitative inquiry ASET-1048 Human Profilin 1 ELISA Kit (AC2459) Quantitative inquiry ASET-1250 Human ASIP ELISA Kit (AC2661) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket